I wrote to the Health Minister about this yesterday. Women with breast cancer and endometriosis will be denied a critical drug "for commercial reasons", while men with prostate cancer will still be able to access it.
Our PBS is still awaiting the reform called for by the Health Technology Assessment review, and that's costing vulnerable Australians.
https://t.co/0A7L9FNVqD